TD Cowen Raises its Price Target on Roivant Sciences (ROIV)

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the 15 High Growth Stocks to Buy and Hold for the Next Decade.

On May 21, 2026, TD Cowen raised the firm’s price target on Roivant Sciences Ltd. (NASDAQ:ROIV) to $41 from $38 and maintained a Buy rating on the shares. TD Cowen said IMVT-1402 toplined impressive Ph2b D2T RA data, with ACR20 of 73%, ACR50 of 55%, and ACR70 of 36%. The firm also said Roivant has many more catalysts ahead.

Citi also raised the firm’s price target on Roivant Sciences Ltd. (NASDAQ:ROIV) to $42 from $35 and maintained a Buy rating on the shares. Citi said it sees further upside from Roivant’s second half of 2026 data catalysts and kept the stock as a top pick following the IMVT-1402 data.

TD Cowen Raises its Price Target on Roivant Sciences (ROIV)

A day earlier, Roivant Sciences Ltd. (NASDAQ:ROIV) reported fiscal Q4 EPS of 28c, compared to the consensus estimate of (35c). Revenue totaled $2.52M, versus the consensus estimate of $3.91M. CEO Matt Gline said the positive Period 1 data from the IMVT-1402 trial in D2T RA showed “exciting potential” for a new treatment approach in RA patients who have failed multiple prior therapies. Gline also pointed to the FDA’s Breakthrough Therapy Designation for brepocitinib in cutaneous sarcoidosis and said the company expects several second-half 2026 updates, including brepocitinib’s expected launch in DM by the end of September and data in NIU, CLE, PH-ILD, and D2T RA.

Roivant Sciences Ltd. (NASDAQ:ROIV) focuses on the discovery, development, and commercialization of medicines and technologies.

While we acknowledge the risk and potential of ROIV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ROIV and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1